HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frances M Platt Selected Research

Lysosomal Storage Diseases (Lysosomal Storage Disease)

1/2022Vesicle cholesterol controls exocytotic fusion pore.
1/2021Acetyl-leucine slows disease progression in lysosomal storage disorders.
4/2020Beneficial Effects of Acetyl-DL-Leucine (ADLL) in a Mouse Model of Sandhoff Disease.
1/2020Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity.
11/2016Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway.
1/2016Urinary excretion and metabolism of miglustat and valproate in patients with Niemann-Pick type C1 disease: One- and two-dimensional solution-state (1)H NMR studies.
1/2016Immune dysfunction in Niemann-Pick disease type C.
2/2014RIPK3 as a potential therapeutic target for Gaucher's disease.
3/2012Early glial activation, synaptic changes and axonal pathology in the thalamocortical system of Niemann-Pick type C1 mice.
8/2011Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frances M Platt Research Topics

Disease

27Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
01/2022 - 08/2004
17Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2022 - 05/2004
14Sandhoff Disease (Sandhoff's Disease)
01/2021 - 08/2002
13Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 08/2003
11Gaucher Disease (Gaucher's Disease)
01/2020 - 01/2002
6Disease Progression
01/2021 - 11/2004
6GM2 Gangliosidoses (GM2 Gangliosidosis)
01/2021 - 08/2002
6Infertility (Sterility)
12/2007 - 12/2002
5Inflammation (Inflammations)
01/2022 - 11/2004
5GM1 Gangliosidosis (Gangliosidosis GM1)
01/2021 - 05/2004
5Gangliosidoses (Gangliosidosis)
01/2017 - 08/2003
3Parkinson Disease (Parkinson's Disease)
01/2022 - 11/2019
3Nervous System Diseases (Neurological Disorders)
01/2021 - 06/2009
3Sphingolipidoses (Sphingolipidosis)
04/2020 - 11/2002
3Neuroinflammatory Diseases
02/2020 - 07/2014
3Metabolic Diseases (Metabolic Disease)
01/2018 - 06/2010
3Tay-Sachs Disease
01/2018 - 01/2015
3Infections
11/2016 - 05/2006
3Fabry Disease (Fabry's Disease)
01/2016 - 06/2010
3Body Weight (Weight, Body)
07/2014 - 05/2004
3Male Infertility (Male Sterility)
06/2008 - 04/2005
2Mucopolysaccharidoses
01/2022 - 02/2020
2Memory Disorders (Memory Loss)
01/2022 - 01/2017
2Crohn Disease (Crohn's Disease)
01/2022 - 01/2017
2Ataxia (Dyssynergia)
01/2021 - 04/2020
2Gliosis
02/2020 - 01/2017
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
12/2017 - 12/2015
2Liver Diseases (Liver Disease)
01/2017 - 10/2016
2Mucolipidoses (Sialidosis)
09/2014 - 08/2011
2Alzheimer Disease (Alzheimer's Disease)
11/2010 - 07/2008
2Congenital Abnormalities (Deformity)
12/2007 - 04/2005
2Neoplasms (Cancer)
04/2007 - 09/2004
2Teratozoospermia
01/2007 - 04/2005
2Atherosclerosis
09/2004 - 02/2002
2Hepatitis B
02/2004 - 01/2002
1Mucopolysaccharidosis III (Sanfilippo Syndrome)
01/2022
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Acute-Phase Reaction
12/2021
1Breast Neoplasms (Breast Cancer)
09/2021
1Osteoporosis
09/2021
1Vertigo (Positional Vertigo)
01/2021
1Hereditary Sensory and Autonomic Neuropathies (HSAN)
01/2021
1Cerebellar Ataxia (Dysmetria)
04/2020
1Tangier Disease
01/2020
1Hemosiderosis
01/2019
1Bacterial Infections (Bacterial Infection)
01/2019

Drug/Important Bio-Agent (IBA)

20GlycosphingolipidsIBA
01/2022 - 11/2002
15EnzymesIBA
01/2021 - 01/2002
15miglustat (Zavesca)FDA Link
01/2020 - 08/2003
14LipidsIBA
01/2022 - 08/2004
13GangliosidesIBA
01/2020 - 08/2003
12CholesterolIBA
01/2022 - 11/2009
9Pharmaceutical PreparationsIBA
01/2021 - 05/2004
9SphingolipidsIBA
01/2020 - 11/2002
9CalciumIBA
11/2016 - 08/2003
8Proteins (Proteins, Gene)FDA Link
02/2020 - 07/2008
6Glucosylceramidase (Glucocerebrosidase)IBA
01/2022 - 11/2002
6Biomarkers (Surrogate Marker)IBA
11/2021 - 02/2009
6G(M2) Ganglioside (Ganglioside GM2)IBA
04/2020 - 08/2003
6Imino SugarsIBA
12/2007 - 01/2002
5SugarsIBA
06/2010 - 11/2002
4Lysergic Acid Diethylamide (LSD)IBA
01/2022 - 08/2011
4migalastatIBA
05/2008 - 05/2004
3Glucosylceramides (Glucocerebrosides)IBA
12/2017 - 11/2002
3GlucosidasesIBA
01/2017 - 08/2004
2Heparitin Sulfate (Heparan Sulfate)IBA
01/2022 - 02/2020
2GalactosidasesIBA
01/2021 - 09/2012
2acetylleucineIBA
01/2021 - 04/2020
2Leucine (L-Leucine)FDA Link
01/2021 - 01/2021
2HydrolasesIBA
01/2020 - 11/2019
2Hexosaminidases (Hexosaminidase)IBA
01/2020 - 08/2002
2AntigensIBA
11/2019 - 10/2008
2G(M3) GangliosideIBA
02/2018 - 01/2017
2CeramidesIBA
12/2017 - 08/2004
2SphingosineIBA
01/2016 - 11/2008
2ceramide glucosyltransferaseIBA
12/2015 - 09/2004
2Ibuprofen (Motrin)FDA LinkGeneric
07/2014 - 11/2004
2lysosomal proteinsIBA
07/2010 - 08/2003
2beta-N-AcetylhexosaminidasesIBA
06/2010 - 05/2008
2GlucosyltransferasesIBA
06/2010 - 08/2004
1Glucosamine (Dona)IBA
01/2022
1Acetyl Coenzyme A (Acetyl-CoA)IBA
01/2022
1AcetyltransferasesIBA
01/2022
1Fatty Acids (Saturated Fatty Acids)IBA
12/2021
1Selective Estrogen Receptor Modulators (SERM)IBA
09/2021
1Serine C-PalmitoyltransferaseIBA
01/2021
1Neuroprotective AgentsIBA
01/2021
11-deoxysphingolipidIBA
01/2021
1Keratan SulfateIBA
02/2020
1sialogangliosidesIBA
02/2020
1GlycosaminoglycansIBA
02/2020
1Synapsins (Synapsin I)IBA
01/2020
1Benzoic Acid (Potassium Benzoate)FDA Link
01/2019
1DeferasiroxFDA Link
01/2019

Therapy/Procedure

20Therapeutics
01/2022 - 01/2003
4Enzyme Replacement Therapy
01/2018 - 04/2008
4Oral Administration
01/2016 - 12/2002
2Contraception (Birth Control)
12/2007 - 12/2002
1Off-Label Use
01/2021
1Treatment Delay
01/2021